501 related articles for article (PubMed ID: 31212911)
1. Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus?
Coco C; Sgarra L; Potenza MA; Nacci C; Pasculli B; Barbano R; Parrella P; Montagnani M
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212911
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics of type 2 diabetes mellitus and weight change - a tool for precision medicine?
Ling C; Bacos K; Rönn T
Nat Rev Endocrinol; 2022 Jul; 18(7):433-448. PubMed ID: 35513492
[TBL] [Abstract][Full Text] [Related]
3. Type 2 diabetes mellitus and cardiovascular risk; what the pharmacotherapy can change through the epigenetics.
Andreeva-Gateva PA; Mihaleva ID; Dimova II
Postgrad Med; 2020 Mar; 132(2):109-125. PubMed ID: 31615302
[TBL] [Abstract][Full Text] [Related]
4. Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?
Prattichizzo F; Giuliani A; De Nigris V; Pujadas G; Ceka A; La Sala L; Genovese S; Testa R; Procopio AD; Olivieri F; Ceriello A
Diabetes Obes Metab; 2016 Sep; 18(9):855-67. PubMed ID: 27161301
[TBL] [Abstract][Full Text] [Related]
5. The endothelium and vascular inflammation in diabetes.
Hartge MM; Unger T; Kintscher U
Diab Vasc Dis Res; 2007 Jun; 4(2):84-8. PubMed ID: 17654441
[TBL] [Abstract][Full Text] [Related]
6. Personalized medicine and type 2 diabetes: lesson from epigenetics.
Raciti GA; Nigro C; Longo M; Parrillo L; Miele C; Formisano P; Béguinot F
Epigenomics; 2014 Apr; 6(2):229-38. PubMed ID: 24811791
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic flexibility in metabolic regulation: disease cause and prevention?
Kirchner H; Osler ME; Krook A; Zierath JR
Trends Cell Biol; 2013 May; 23(5):203-9. PubMed ID: 23277089
[TBL] [Abstract][Full Text] [Related]
8. Novel epigenetic-sensitive clinical challenges both in type 1 and type 2 diabetes.
Sommese L; Benincasa G; Lanza M; Sorriento A; Schiano C; Lucchese R; Alfano R; Nicoletti GF; Napoli C
J Diabetes Complications; 2018 Nov; 32(11):1076-1084. PubMed ID: 30190170
[TBL] [Abstract][Full Text] [Related]
9. Unraveling the epigenetic fabric of type 2 diabetes mellitus: pathogenic mechanisms and therapeutic implications.
Jazieh C; Arabi TZ; Asim Z; Sabbah BN; Alsaud AW; Alkattan K; Yaqinuddin A
Front Endocrinol (Lausanne); 2024; 15():1295967. PubMed ID: 38323108
[TBL] [Abstract][Full Text] [Related]
10. The Importance of Precision Medicine in Type 2 Diabetes Mellitus (T2DM): From Pharmacogenetic and Pharmacoepigenetic Aspects.
Khatami F; Mohajeri-Tehrani MR; Tavangar SM
Endocr Metab Immune Disord Drug Targets; 2019; 19(6):719-731. PubMed ID: 31122183
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic modification and therapeutic targets of diabetes mellitus.
Singh R; Chandel S; Dey D; Ghosh A; Roy S; Ravichandiran V; Ghosh D
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32815547
[TBL] [Abstract][Full Text] [Related]
12. Recent developments on the role of epigenetics in obesity and metabolic disease.
van Dijk SJ; Tellam RL; Morrison JL; Muhlhausler BS; Molloy PL
Clin Epigenetics; 2015; 7():66. PubMed ID: 27408648
[TBL] [Abstract][Full Text] [Related]
13. The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?
Porter KE; Riches K
Clin Sci (Lond); 2013 Aug; 125(4):167-82. PubMed ID: 23634936
[TBL] [Abstract][Full Text] [Related]
14. Antidiabetic agents and endothelial dysfunction - beyond glucose control.
Eriksson L; Nyström T
Basic Clin Pharmacol Toxicol; 2015 Jul; 117(1):15-25. PubMed ID: 25827165
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation in diabetic vascular complications.
Jin J; Wang X; Zhi X; Meng D
J Mol Endocrinol; 2019 Nov; 63(4):R103-R115. PubMed ID: 31600719
[TBL] [Abstract][Full Text] [Related]
16. Phytochemicals as Potential Epidrugs in Type 2 Diabetes Mellitus.
Ramírez-Alarcón K; Victoriano M; Mardones L; Villagran M; Al-Harrasi A; Al-Rawahi A; Cruz-Martins N; Sharifi-Rad J; Martorell M
Front Endocrinol (Lausanne); 2021; 12():656978. PubMed ID: 34140928
[TBL] [Abstract][Full Text] [Related]
17. Recent progress in genetic and epigenetic research on type 2 diabetes.
Kwak SH; Park KS
Exp Mol Med; 2016 Mar; 48(3):e220. PubMed ID: 26964836
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes Mellitus.
Hossan T; Kundu S; Alam SS; Nagarajan S
Endocr Metab Immune Disord Drug Targets; 2019; 19(6):775-786. PubMed ID: 30827271
[TBL] [Abstract][Full Text] [Related]
19. The epigenetic landscape in the cardiovascular complications of diabetes.
Costantino S; Ambrosini S; Paneni F
J Endocrinol Invest; 2019 May; 42(5):505-511. PubMed ID: 30291588
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Remodeling in Obesity-Related Vascular Disease.
Masi S; Ambrosini S; Mohammed SA; Sciarretta S; Lüscher TF; Paneni F; Costantino S
Antioxid Redox Signal; 2021 May; 34(15):1165-1199. PubMed ID: 32808539
[No Abstract] [Full Text] [Related]
[Next] [New Search]
